Delivery Order SPE2DB22D3004-SPE2DB25FPL66

Award Date 2/10/25
Potential Completion Date 2/11/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,153.24 Firm Fixed Price Delivery Order contract is for the provision of emtricitabine-tenofovir 200-300 mg pharmaceutical products. The contract has an ultimate completion date of November 13, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,211.12, is a Delivery Order for the supply of EMTRICITABINE-TENOFV 200-300MG UU 30S, a pharmaceutical product. The contract has an ultimate completion date of April 27, 2023. This contract award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,516.82, is for the delivery of emtricitabine-tenofv 200-300mg pharmaceutical products. It is a Firm Fixed Price Delivery Order contract with a completion date of September 26, 2023. The contract is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $40,784.69 and has an ultimate completion date of January 29, 2025. The contract is for the supply of emtricitabine-tenofv 200-300mg medication to support military healthcare programs. Amerisourcebergen holds a significant Indefinite Delivery...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The contract, valued at $1,223.20, is a Firm Fixed Price Delivery Order with a performance period through January 23, 2025. The award is for the supply of emtricitabine-tenofovir 200-300mg medication. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,975.23, is for the delivery of Emtricitabine-Tenofv 200-300mg medication in 30-count units. The contract is a Firm Fixed Price Delivery Order with a completion date of November 18, 2024. Amerisourcebergen is a for-profit organization registered in the System for Award...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) on September 10, 2024. The $1,625.00 firm fixed-price delivery order (Contract #SPE2DB20D3103|SPE2DB24FQ2F0) is for the supply of emtricitabine-tenofovir 200-300 mg pharmaceutical products. The contract has an ultimate completion date of September 11, 2024 and was not set aside for any specific business classification. Amerisourcebergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,058.82 and is for the delivery of EMTRICITABINE-TENOFV 200-300MG UU 30S, a pharmaceutical product. The contract is a Firm Fixed Price type and has an ultimate completion date of January 30, 2025. There is no set-aside designation specified for this award. AmerisourceBergen holds...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $1,672.26 to provide 4,563,918,225 units of the pharmaceutical product emtricitabine-tenofovir 200-300 mg. The contract has a period of performance through March 12, 2024 and was not set aside for any specific socioeconomic program. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Emtricitabine-Tenofovir 200-300 mg medication. The $5,104.14 firm-fixed-price contract has a completion date of January 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FPL66
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,117.62, is a Firm Fixed Price Delivery Order for the supply of EMTRICITABINE-TENOFV 200-300MG UU 30S, a type of pharmaceutical product. The contract has an ultimate completion date of February 11, 2025.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

This contract award does not have a set-aside designation, indicating open competition.

Generated 5/12/25, 10:25 AM